Published in
Elsevier, The Lancet Oncology, 3(22), p. 321-331, 2021
DOI: 10.1016/s1470-2045(20)30742-7
Links
Tools
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial
Journal article published in 2021 by
Bjørn Henning Grønberg,
Kristin Toftaker Killingberg,
Øystein Fløtten,
Odd Terje Brustugun,
Kjersti Hornslien,
Tesfaye Madebo,
Seppo Wang Langer,
Tine Schytte,
Jan Nyman,
Signe Risum,
Georgios Tsakonas 
,
Jens Engleson,
Tarje Onsøien Halvorsen
,
Jens Engleson,
Tarje Onsøien Halvorsen
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 